Aspira Pathlab & Diagnostics Ltd — Board Meeting, 16-05-2025: Board Meeting

Aspira Pathlab & Diagnostics Limited has announced a board meeting on which it approved the financial results for the quarter and half-year ended March 31, 2025, with the auditors issuing an unmodified opinion. The company appointed M/s. Nilesh A. Pradhan & Co. LLP as Secretarial Auditor for five years (subject to shareholder approval) and M/s. Vishal J Bhanushali & Associates as Internal Auditor for FY 2025-26. Dr. Pankaj Shah was re-appointed as Managing Director & CEO for three years starting August 1, 2025, pending shareholder approval. The board also approved a postal ballot process related to his re-appointment. The standalone financials showed profit after tax of Rs. 207.26 Lakhs with total income of Rs. 2,238.79 Lakhs and EBITDA improving over the previous year. The consolidated results, including the associate Aspira DNA Diagnostics Gujarat LLP, showed a profit after tax of Rs. 202.26 Lakhs. The company continues to focus solely on pathology services.